abstract |
The invention provides antibodies that recognize B cell maturation antigen (BCMA) and bind naive B cells, plasma cells and/or memory B cells. The invention also provides methods of reducing naive B cells, plasma cells, and memory B cells, and methods of treating B cell-related disorders, including lymphomas and autoimmune diseases. |